Autologous bone marrow-derived mesenchymal stem cells and endothelial progenitor cells transplantation showed potential benefits for type 2 diabetes mellitus Filipino patients: a case series

被引:0
作者
De Guzman, Mary Suzette A. [1 ]
Apelado, Maria Perlita B. [1 ]
Panuelos, Jennifer P. [1 ]
Heralde III, Francisco M. [1 ,2 ]
Relacion, Patrick R. [2 ]
Bilbao, Abigail B. [1 ]
Tan-Liu, Nelia S. [1 ]
Barzaga, Maria Teresa A. [1 ,3 ]
机构
[1] Lung Ctr Philippines, Dept Pathol, Mol Diagnost & Cellular Therapeut Lab, Quezon Ave, Quezon City, Philippines
[2] Univ Philippines, Coll Med, Dept Biochem & Mol Biol, Manila, Philippines
[3] De La Salle Hlth Sci Inst, Coll Med, Dasmarinas, Cavite, Philippines
来源
BIOMEDICAL RESEARCH AND THERAPY | 2024年 / 11卷 / 04期
关键词
type-2; diabetes; stem cell therapy; bone marrow-derived stem cell; HbA1c;
D O I
10.15419/bmrat.v11i4.878
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Introduction : Type 2 diabetes mellitus (T2DM) is a serious metabolic disorder characterized by hyperglycemia and insulin resistance. Long-standing T2DM may lead to various macro- and microvascular complications such as diabetic nephropathy, neuropathy, and retinopathy. Currently available treatments for T2DM target high plasma glucose levels but do not address T2DM-associated complications. In this report, the therapeutic application of mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs) transplantation in improving diabetic blood monitoring parameters among selected T2DM patients was investigated. Methods : Five Filipino patients with T2DM diagnosed for more than five years agreed to participate in the autologous bone marrow -derived stem cell transplantation. Five milliliters (mL) per kilogram (kg) of bone marrow was collected from the patients following standard procedures, and bone marrow -derived stem cells underwent quantification, genetic typing, microbial analysis, and quality control before being infused into the patients. MSCs and EPCs were intravenously transfused into the patients once a month for 6 months. Fasting blood glucose (FBG), blood urea nitrogen (BUN), glycated hemoglobin (HbA1c), and creatinine (CREA) levels were recorded pre- and post -stem cell transplantation. Results : The findings of the study revealed that the administration of autologous bone marrow -derived stem cells showed no adverse effects and improved or controlled the blood monitoring levels in most patients. Four out of five patients showed a reduction in their BUN (mean reduction = 2.246) and HbA1c (mean reduction = 0.74%) and maintained their creatinine levels within the normal range following the 6 months of infusion. Meanwhile, three out of five patients showed a decrease in FBG levels (mean reduction = 1.484 mmol/L). Conclusion : This preliminary report suggests the potential of autologous bone marrow -derived stem cell transplantation for the treatment and management of T2DM. Future studies may focus on examining other parameters such as C -peptide levels and evaluate the efficacy and safety of autologous MSCs and EPCs in the long-term management of T2DM.
引用
收藏
页码:6326 / 6332
页数:7
相关论文
共 24 条
  • [1] Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management
    Alam, Saruar
    Hasan, Md. Kamrul
    Neaz, Sharif
    Hussain, Nazmul
    Hossain, Md. Faruk
    Rahman, Tania
    [J]. DIABETOLOGY, 2021, 2 (02): : 36 - 50
  • [2] Glycaemic variability in diabetes: clinical and therapeutic implications
    Ceriello, Antonio
    Monnier, Louis
    Owens, David
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (03) : 221 - 230
  • [3] IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
    Cho, N. H.
    Shaw, J. E.
    Karuranga, S.
    Huang, Y.
    Fernandes, J. D. da Rocha
    Ohlrogge, A. W.
    Malanda, B.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 138 : 271 - 281
  • [4] An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells
    Chu, Dinh-Toi
    Thuy Nguyen Thi Phuong
    Nguyen Le Bao Tien
    Dang Khoa Tran
    Vo Van Thanh
    Thuy Luu Quang
    Dang Tien Truong
    Van Huy Pham
    Vo Truong Nhu Ngoc
    Thien Chu-Dinh
    Kushekhar, Kushi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
  • [5] Department of Health-Philippines, 2013, Rules and Regulations Governing the Accreditation of Health Facilities Engaging in Human Stem Cell and Cell-Based or Cellular Therapies in the Philippines
  • [6] Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy
    Fan, Xing-Liang
    Zhang, Yuelin
    Li, Xin
    Fu, Qing-Ling
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (14) : 2771 - 2794
  • [7] Quick and effective method of bone marrow mesenchymal stem cell extraction
    Gudleviciene, Zivile
    Kundrotas, Gabrielis
    Liudkeviciene, Regina
    Rascon, Jelena
    Jurga, Marcin
    [J]. OPEN MEDICINE, 2015, 10 (01): : 44 - 49
  • [8] Kim JW, 2019, ROADMAP TO NONHEMATOPOIETIC STEM CELL-BASED THERAPEUTICS: FROM THE BENCH TO THE CLINIC, P251, DOI 10.1016/B978-0-12-811920-4.00010-0
  • [9] Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cells
    Liem Thanh Nguyen
    Hoang, Duc M.
    Nguyen, Kien T.
    Bui, Duc M.
    Nguyen, Hieu T.
    Le, Hong T. A.
    Hoang, Van T.
    Bui, Hue T. H.
    Dam, Phuong T. M.
    Hoang, Xuan T. A.
    Ngo, Anh T. L.
    Le, Hang M.
    Phung, Nhi Y.
    Vu, Duc M.
    Duong, Trung T.
    Nguyen, Tu D.
    Ha, Lien T.
    Bui, Hoa T. P.
    Nguyen, Hoa K.
    Heke, Michael
    Bui, Anh, V
    [J]. STEM CELLS TRANSLATIONAL MEDICINE, 2021, 10 (09) : 1266 - 1278
  • [10] Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis
    Madani, Sedigheh
    Amanzadi, Mahdiyeh
    Aghayan, Hamid Reza
    Setudeh, Aria
    Rezaei, Negar
    Rouhifard, Mahtab
    Larijani, Bagher
    [J]. SYSTEMATIC REVIEWS, 2022, 11 (01)